Japan's Olympus names Stefan Kaufmann as next CEO in medtech pivot
Oct 26, 2022
1 min read
Tokyo, October 21. 2022 (Reuters) -- Olympus Corp (7733.T) said on Friday that Stefan Kaufmann would become the endoscope maker's chief executive next year, becoming one of the few foreigners to run a major Japanese company.
London, February 25, 2026 (Proactive) -- GSK has agreed to acquire Canadian biotech 35Pharma for $950 million in cash, adding a clinical-stage pulmonary hypertension therapy to its pipeline. The com
Boca Raton, FL, February 18, 2026 (Globe Newswire) -- LIXTE Biotechnology Holdings, Inc., a clinical-stage oncology company developing small-molecule cancer therapies and radiotherapy technologies,
Waltham, MA, February 18, 2026 (Business Wire) -- Korsana Biosciences announced it has emerged from stealth mode with $175 million in total funding to advance novel therapies for neurodegenerative d
Comments